Product Code: A12055
According to a new report published by Allied Market Research, titled, "Lung Monitoring Devices Market," The lung monitoring devices market was valued at $3.3 billion in 2022, and is estimated to reach $6.1 billion by 2032, growing at a CAGR of 6.6% from 2023 to 2032.
Lung monitoring devices are used for precise and efficient monitoring of lung function for respiratory conditions, including chronic obstructive pulmonary disease (COPD), cystic fibrosis, and post-transplant patients. These devices aid in managing symptoms and help reduce exacerbations of multiple lung disorders such as asthma and COPD.
The growth of the lung monitoring devices market is driven by surge in incidence of respiratory diseases, increase in availability & affordability of healthcare treatment, and rise in number of advanced product launches. For instance, in March 2021, Vyaire Medical, a leading pharmaceutical company, announced the launch of the AioCare (HealthUp SA, Poland) mobile spirometry system in more than 15 countries across Europe, the Middle East, and Australia. Spirometry is the most common type of pulmonary function or breathing test.
Moreover, large medical technology firms are increasingly focusing on acquiring companies that provide solutions for lung monitoring devices, which is expected to notably contribute toward the market growth. Prominent players in the global lung monitoring devices market have adopted various strategies such as product launches, acquisition, and investments in R&D for advancement in lung monitoring devices to strengthen their position in the market and sustain the competitive environment.
Moreover, alarming increase in prevalence of COPD, technological advancements in lung monitoring devices, and rise in the number of accidents and trauma are some of the key factors driving the growth of the market. Furthermore, rise in levels of air pollution in metropolitan cities and changes in lifestyles involving cigarette smoking notably contribute toward the growing prevalence of pulmonary diseases. However, availability of alternative treatments for lung monitoring devices and lack of awareness regarding lung diseases hamper the market growth. Conversely, increased application of lung monitoring devices among the geriatric population is expected to provide lucrative opportunities for the growth of the market in the near future. In addition, extensive R&D activities in the field of lung monitoring devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market during the forecast period.
The global lung monitoring devices market is segmented into product type, end user, and region. On the basis of product type, the market is classified spirometers, pulse oximeters, capnographs, and others. The spirometers segment further bifurcated into hand-held and table-top. The pulse oximeter segment further classified into bedside pulse oximeter, fingertip pulse oximeter, hand held pulse oximeter, wrist worn pulse oximeter and pediatric pulse oximeter.
Depending on end user, it is classified into hospitals, homecare, and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include: GE Healthcare, Hill-Rom, Inc., Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, Resmed Inc., Smiths Medical, Vitalograph Ltd., and Vyaire Medical.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the lung monitoring devices market analysis from 2022 to 2032 to identify the prevailing lung monitoring devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the lung monitoring devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global lung monitoring devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End User
- Hospitals
- Homecare
- Others
By Product Type
- Pulse Oximeters
- Type
- Bedside Pulse Oximeter
- Fingertip Pulse Oximeter
- Hand held Pulse Oximeter
- Wrist worn Pulse Oximeter
- Pediatric Pulse Oximeter
- Capnographs
- Others
- Spirometers
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- Baxter International Inc.
- Becton, Dickinson and Company
- ICU Medical Inc.
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
- Nihon Kohden Corporation
- ResMed Inc.
- Teleflex Incorporated.
- Vyaire Medical, Inc.
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter's five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Upsurge in geriatric population
- 3.4.1.2. Rise in incidence of respiratory diseases
- 3.4.1.3. Rapid technological advancements
- 3.4.2. Restraints
- 3.4.2.1. Lack of awareness regarding respiratory diseases
- 3.4.3. Opportunities
- 3.4.3.1. Rise in preference for home healthcare
- 3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: LUNG MONITORING DEVICES MARKET, BY PRODUCT TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Spirometers
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Spirometers Lung Monitoring Devices Market by Type
- 4.3. Pulse Oximeters
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Pulse Oximeters Lung Monitoring Devices Market by Type
- 4.4. Capnographs
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- 4.5. Others
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
CHAPTER 5: LUNG MONITORING DEVICES MARKET, BY END USER
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Hospitals
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Homecare
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
CHAPTER 6: LUNG MONITORING DEVICES MARKET, BY REGION
- 6.1. Overview
- 6.1.1. Market size and forecast By Region
- 6.2. North America
- 6.2.1. Key trends and opportunities
- 6.2.2. Market size and forecast, by Product Type
- 6.2.3. Market size and forecast, by End User
- 6.2.4. Market size and forecast, by country
- 6.2.4.1. U.S.
- 6.2.4.1.1. Key market trends, growth factors and opportunities
- 6.2.4.1.2. Market size and forecast, by Product Type
- 6.2.4.1.3. Market size and forecast, by End User
- 6.2.4.2. Canada
- 6.2.4.2.1. Key market trends, growth factors and opportunities
- 6.2.4.2.2. Market size and forecast, by Product Type
- 6.2.4.2.3. Market size and forecast, by End User
- 6.2.4.3. Mexico
- 6.2.4.3.1. Key market trends, growth factors and opportunities
- 6.2.4.3.2. Market size and forecast, by Product Type
- 6.2.4.3.3. Market size and forecast, by End User
- 6.3. Europe
- 6.3.1. Key trends and opportunities
- 6.3.2. Market size and forecast, by Product Type
- 6.3.3. Market size and forecast, by End User
- 6.3.4. Market size and forecast, by country
- 6.3.4.1. Germany
- 6.3.4.1.1. Key market trends, growth factors and opportunities
- 6.3.4.1.2. Market size and forecast, by Product Type
- 6.3.4.1.3. Market size and forecast, by End User
- 6.3.4.2. France
- 6.3.4.2.1. Key market trends, growth factors and opportunities
- 6.3.4.2.2. Market size and forecast, by Product Type
- 6.3.4.2.3. Market size and forecast, by End User
- 6.3.4.3. UK
- 6.3.4.3.1. Key market trends, growth factors and opportunities
- 6.3.4.3.2. Market size and forecast, by Product Type
- 6.3.4.3.3. Market size and forecast, by End User
- 6.3.4.4. Italy
- 6.3.4.4.1. Key market trends, growth factors and opportunities
- 6.3.4.4.2. Market size and forecast, by Product Type
- 6.3.4.4.3. Market size and forecast, by End User
- 6.3.4.5. Spain
- 6.3.4.5.1. Key market trends, growth factors and opportunities
- 6.3.4.5.2. Market size and forecast, by Product Type
- 6.3.4.5.3. Market size and forecast, by End User
- 6.3.4.6. Rest of Europe
- 6.3.4.6.1. Key market trends, growth factors and opportunities
- 6.3.4.6.2. Market size and forecast, by Product Type
- 6.3.4.6.3. Market size and forecast, by End User
- 6.4. Asia-Pacific
- 6.4.1. Key trends and opportunities
- 6.4.2. Market size and forecast, by Product Type
- 6.4.3. Market size and forecast, by End User
- 6.4.4. Market size and forecast, by country
- 6.4.4.1. China
- 6.4.4.1.1. Key market trends, growth factors and opportunities
- 6.4.4.1.2. Market size and forecast, by Product Type
- 6.4.4.1.3. Market size and forecast, by End User
- 6.4.4.2. Japan
- 6.4.4.2.1. Key market trends, growth factors and opportunities
- 6.4.4.2.2. Market size and forecast, by Product Type
- 6.4.4.2.3. Market size and forecast, by End User
- 6.4.4.3. India
- 6.4.4.3.1. Key market trends, growth factors and opportunities
- 6.4.4.3.2. Market size and forecast, by Product Type
- 6.4.4.3.3. Market size and forecast, by End User
- 6.4.4.4. Australia
- 6.4.4.4.1. Key market trends, growth factors and opportunities
- 6.4.4.4.2. Market size and forecast, by Product Type
- 6.4.4.4.3. Market size and forecast, by End User
- 6.4.4.5. South Korea
- 6.4.4.5.1. Key market trends, growth factors and opportunities
- 6.4.4.5.2. Market size and forecast, by Product Type
- 6.4.4.5.3. Market size and forecast, by End User
- 6.4.4.6. Rest of Asia-Pacific
- 6.4.4.6.1. Key market trends, growth factors and opportunities
- 6.4.4.6.2. Market size and forecast, by Product Type
- 6.4.4.6.3. Market size and forecast, by End User
- 6.5. LAMEA
- 6.5.1. Key trends and opportunities
- 6.5.2. Market size and forecast, by Product Type
- 6.5.3. Market size and forecast, by End User
- 6.5.4. Market size and forecast, by country
- 6.5.4.1. Brazil
- 6.5.4.1.1. Key market trends, growth factors and opportunities
- 6.5.4.1.2. Market size and forecast, by Product Type
- 6.5.4.1.3. Market size and forecast, by End User
- 6.5.4.2. Saudi Arabia
- 6.5.4.2.1. Key market trends, growth factors and opportunities
- 6.5.4.2.2. Market size and forecast, by Product Type
- 6.5.4.2.3. Market size and forecast, by End User
- 6.5.4.3. South Africa
- 6.5.4.3.1. Key market trends, growth factors and opportunities
- 6.5.4.3.2. Market size and forecast, by Product Type
- 6.5.4.3.3. Market size and forecast, by End User
- 6.5.4.4. Rest of LAMEA
- 6.5.4.4.1. Key market trends, growth factors and opportunities
- 6.5.4.4.2. Market size and forecast, by Product Type
- 6.5.4.4.3. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top player positioning, 2022
CHAPTER 8: COMPANY PROFILES
- 8.1. Koninklijke Philips N.V.
- 8.1.1. Company overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
- 8.2. Masimo Corporation
- 8.2.1. Company overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
- 8.3. Medtronic plc
- 8.3.1. Company overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
- 8.4. Nihon Kohden Corporation
- 8.4.1. Company overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.5. ResMed Inc.
- 8.5.1. Company overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
- 8.6. ICU Medical Inc.
- 8.6.1. Company overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.7. Vyaire Medical, Inc.
- 8.7.1. Company overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.8. Becton, Dickinson and Company
- 8.8.1. Company overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
- 8.9. Teleflex Incorporated.
- 8.9.1. Company overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
- 8.10. Baxter International Inc.
- 8.10.1. Company overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio
- 8.10.6. Business performance